← FDA Drug Approvals (Drugs@FDA)

RINVOQ

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2019-08-16

Drug application

FDA Application #

NDA211675

Application type

New Drug Application

Brand name

RINVOQ

Generic name

UPADACITINIB

Active ingredients

UPADACITINIB

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

ABBVIE

Manufacturer

AbbVie Inc.

First approval

2019-08-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown